FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

16449811000001104: Zestoretic 20 tablets (Lexon (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57577301000001115 Zestoretic 20 tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57577401000001111 Zestoretic 20 tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zestoretic 20 tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zestoretic 20 tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zestoretic 20 tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Zestoretic 20 tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Zestoretic 20 tablets (Lexon (UK) Ltd) Is a Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Zestoretic 20 tablets (Lexon (UK) Ltd) Has active ingredient Lisinopril false Inferred relationship Existential restriction modifier
Zestoretic 20 tablets (Lexon (UK) Ltd) Has active ingredient Hydrochlorothiazide false Inferred relationship Existential restriction modifier
Zestoretic 20 tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Zestoretic 20 tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zestoretic 20 tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zestoretic 20 tablets (Lexon (UK) Ltd) Has specific active ingredient Lisinopril true Inferred relationship Existential restriction modifier
Zestoretic 20 tablets (Lexon (UK) Ltd) Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Zestoretic 20 tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zestoretic 20 tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zestoretic 20 tablets (Lexon (UK) Ltd) Is a Zestoretic 20 true Inferred relationship Existential restriction modifier
Zestoretic 20 tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Zestoretic 20 tablets (Lexon (UK) Ltd) 28 tablet Has AMP True Zestoretic 20 tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start